September 2021 - Page 16 of 35

FridaySep 17, 2021 2:55 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enables Rapid, Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human clinical study HYPER-H21-1. The study evaluated DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension/high blood pressure. “The partial results showed that blood pressure was reduced across both male and female volunteers; it was more pronounced with DehydraTECH-CBD in the study’s first 10 to 50 minutes. These results reinforced the pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic CBD controls,” reads a recent article. Lexaria was also pleased that the subjects of this human clinical study tolerated the DehydraTECH-CBD,…

FridaySep 17, 2021 12:32 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names World-Renowned Thought Leader as Advisory Board Member

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced that Dr. Osama Hamdy, MD, PhD, has joined its advisory board. Hamdy will act as a consultant and will provide invaluable input regarding key opinion leader studies in both the diabetes and metabolic health fields using Nemaura’s glucose monitoring technology. An acclaimed endocrinologist, Hamdy is medical director of the Obesity Clinic Program at the Joslin Diabetes Center; he is also an associate professor of medicine at Harvard Medical School. He has built a stellar reputation as…

FridaySep 17, 2021 12:26 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Segue into Turkey as Natural Gateway to EU Produce Market

Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend shelf life and ensure food safety of fresh fruits and vegetables, today announced its engagement of a local commercial post-harvest expert in Turkey. The expert is well connected in the local produce market, particularly within the citrus sector, to introduce Save Foods to local post-harvest operators with ties to the EU produce market. “The EU is an important market for Save Foods and Turkey is a natural gateway for us,” said Dan Sztybel, chief executive officer of Save Foods Ltd., the company’s…

FridaySep 17, 2021 12:05 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Slated to Participate in Tribe Public Webinar

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has announced that its CEO Eric A. Adams will be a featured presenter at Tribe Public’s upcoming complimentary ZOOM presentation titled “Accelerating The Commercialization of Rare Cannabinoids.” The webinar is scheduled to begin on Sept. 21, 2021, at 11.30 a.m. ET. In addition to Adams, BayMedica Inc. cofounder Shane Johnson will also present during the event. Adams and Johnson’s presentation will be hosted by Tribe Public managing member John F. Heerdink Jr., who will field live questions and pass those on to the presenters. In…

FridaySep 17, 2021 10:53 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Strategic Board Appointment

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced the appointment of Ryan Costello to its board of directors to become effective upon completion of any regulatory and/or other requirements, as applicable. Costello brings to the company significant U.S. government regulatory experience, including areas overseeing cannabis policy. “Mr. Costello will be a very welcome addition to the RWB board as he brings a wealth of experience with solid acumen and a complimentary skill set,” said Brad Rogers, RWB’s chairman and CEO. “He will also deepen the company’s U.S.-based representation,…

FridaySep 17, 2021 10:33 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Schedules Sept. 20 Special Management Call

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced that it will be hosting a special management call on Monday, Sept. 20, 2021; the call will begin at 7:30 a.m. PST. Key members of BevCanna’s management team, including CEO Marcello Leone, CFO John Campbell and President Melise Panetta will participate in the call. The executives will provide an overview of recent corporate developments as well as upcoming milestones. Interested individuals are encouraged to dial in a few minutes before the call to ensure participation. Those in Canada and the…

FridaySep 17, 2021 9:55 am

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Exec to Participate in Upcoming in Mental Health Virtual Conference

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has announced that president and CEO Kelsey Ramsden will be participating in the Advances in Mental Health Virtual Conference. The one-day conference, presented by Maxim Group LLC and hosted by M-Vest, is scheduled for Sept. 22, 2021. Ramsden will be a panel member in two separate sessions held during the virtual event. The panels, which are part of the “Disruptors in the Mental Health Space” series, are titled “The Second Generation – Beyond Psilocybin and MDMA”and “Delivery, Manufacturing and Technology” and will…

FridaySep 17, 2021 9:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Phase Two Growth Plans, CEO Interview on Gamechangers LIVE

FuelPositive announced four new appointments – Nelson Leite and Olushola Ashiru have joined the Board, while Francois Desloges and Jennifer Spencer have been appointed to the Executive Leadership Team The appointments are in a move to actualize Phase Two of the company’s Hydrogen-Ammonia Synthesizer commercial prototype system, critical to its future growth FuelPositive’s CEO expressed enthusiasm with the new appointments, citing that they will be integral to the company’s plans for creating and developing technologies and solutions to fight climate change The company’s CEO also appeared on the Gamechangers LIVE podcast, where he shared his personal story, background, mindset, struggles…

FridaySep 17, 2021 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) designed for people with diabetes and prediabetes sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union, and Nemaura has submitted a premarket approval application to the U.S. FDA Nemaura continues to build a world-class management team Nemaura plans to launch a direct to consumer metabolic health program in 2021, using its glucose monitoring platform at the core of the program Nemaura has several patents (both filed and pending) and substantial trade secrets covering its technology platform…

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

Site Search

Company Search

Month: September 2021